Found 0 matching trials
Empagliflozin and Cardiac Remodelling in People Without Diabetes
PHASE4The purpose of this study is to evaluate the effects of empagliflozin on ca...
Location
Diagnostic Assessment Centre (AMS Diagnostics)
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets
PHASE1To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...
Location
1245.2.1 Boehringer Ingelheim Investigational Site
Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
PHASE3EMPACT (EMPAgliflozin in prevention of chemotherapy-related CardioToxicity)...
Status
Active Not Recruiting
Location
Institute of Hematology and Transfusion Medicine
Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA
PHASE4This is a multi-center, randomised, double-blind, parallel-group, safety an...
Location
Kunisaki Makoto Clinic
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).
PHASE3The aim of the present study is to investigate the safety of BI 10773 treat...
Location
1245.25.10043 Boehringer Ingelheim Investigational Site
Empagliflozin on Patients With Preserved Heart Failure
NAThe proposed research in this application will investigate the effect of em...
Location
Rehab Hussein Werida
Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics
PHASE4The purpose of the EmDia trial is to compare the effects of empagliflozin w...
Location
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Zentrum für Kardiologie, Präventive Kardiologie und Medizinische Prävention
EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
PHASE4The presence of CKD has been linked to the development of HFpEF. Currently,...
Location
National Taiwan University Hospital Hsinchu Branch
Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology
PHASE4The primary aim of this exploratory mechanistic study is to investigate the...
Location
Profil Mainz GmbH & Co. KG
Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients
PHASE3Olanzapine is a thieno-benzodiazepine derivate that is effective managing t...